SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Better-than-expected quarterly results, raised guidance, and a growing backlog signaling strong AI-compute demand drove attention and a sharp after-hours rally. Many traders celebrated the outlook and anticipated short covering, while others questioned whether heavy debt, interest costs, and capital spending will translate into sustainable profits.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and conference call are the main focus, with traders weighing improved profitability and Samsung licensing revenue against an apparent miss versus some analyst estimates; much of the debate centers on the upfront Samsung payment being recognized over the license term. Many are optimistic about recurring licensing income from Micron and stronger margins, while a possible SK Hynix deal or Nasdaq uplisting remains speculation.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis Q3 results missed expectations, intensifying selling and concerns that its high valuation is outpacing commercial revenue and profitability. Bears question its business prospects and commercialization timeline, while bulls point to quantum-technology progress and argue the companys long-term potential outweighs near-term results.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is drawing attention after a sharp selloff despite encouraging CTX310 data showing substantial triglyceride reductions. Traders are debating whether the decline reflects skepticism toward early-stage results or an overreaction, while some point to CASGEVYs ongoing commercial sales as a counterweight.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,011,579 in circulation. The last known price of Autonomi is 0.03102024 USD and is up 12.83 over the last 24 hours. It is currently trading on 15 active market(s) with $148,822.58 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Discussion is fragmented, with much of the chatter confusing Aragons ANT token with Anthropics unrelated IPO ticker. Aragon-focused posts mention its dissolved project and completed token-redemption initiative, alongside speculative reactions to the tokens price move; theres no clear new catalyst established.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holdings Q3 reportrecord sales and an earnings beat, but unchanged full-year growth guidancehas been followed by a sharp selloff. Traders question the quality of the results, citing tariff refunds boost to margins and concerns about direct-to-consumer momentum, while some view the decline as a buying opportunity.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

A stronger-than-expected Q3 report, raised full-year outlook and improving medical-cost trends are fueling hopes that UnitedHealths turnaround is taking hold, with traders also viewing healthcare as a defensive alternative amid tech volatility. Bullish calls for a continued rebound compete with frustration over choppy price action and concerns about Medicare Advantage scrutiny and political risk.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Waves Q3 results are driving attention, with shares selling off despite revenue growth as traders focus on softer bookings, high costs and the gap between its small current revenue base and lofty valuation. Bulls point to a sharply higher backlog and growing commercial deployments, while skeptics question when those orders will convert into meaningful revenue and profitability.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Uncertainty over DefenCaths post-TDAPA reimbursement and adoption is driving attention, after DaVita warned that reimbursement could decline through 2027 and the stock sold off. Traders disagree on whether that signals weaker sales: CMS set the Q1 2027 add-on at $8.32 per treatment, while future quarterly rates and uptake remain uncertain; a Fresenius observational comparison with ClearGuard has added to the debate.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,103,675.095707 in circulation. The last known price of Algorand is 0.08996747 USD and is down -2.64 over the last 24 hours. It is currently trading on 586 active market(s) with $54,766,948.47 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

Algorand is drawing attention amid continued price weakness and bearish technical signals, with traders debating whether the decline will deepen or has created an accumulation opportunity. Bulls cite tokenization and the networks technology as long-term potential, while skeptics point to ALGOs prolonged underperformance and see rallies as temporary.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alcoa Corp: UBS downgrades stock, says alumina ’down and out’

Investing.com -- UBS cut its rating for  Alcoa  (NYSE:AA) Corp. to Neutral from Buy on Thursday, warning that the outlook for alumina remains weak and the company’s valuation is no longer compelling following a recent stock rebound.

BofA downgrades Alcoa on weaker Aluminum, Alumina outlook

Investing.com -- Bank of America downgraded  Alcoa  (NYSE:AA) Corp to Underperform from Buy given a weaker outlook for aluminum and alumina prices and growing uncertainty around demand, especially into 2025 and 2026.

Alcoa shares up after Q4 beat, forecasts stable alumina production for 2025

Investing.com --  Alcoa  Corp (NYSE:AA) posted fourth-quarter adjusted earnings of $1.04 per share, beating analysts' expectations by 11 cents, while revenue climbed to $3.49 billion, beating consensus estimates of $3.29 billion. Shares of the company were up more than 3% in aftermarket trading.

Neutral Sentiment

Yes, by year-end

Yes, but not this year

No, he stays as CEO

He steps down on his own

Do you think Jensen Huang will be removed as Nvidia’s ($NVDA) CEO?

Stocktwits

Do you think Jensen Huang will be removed as Nvidia’s (

Feed

News

Sentiment

Fundamentals

Info

About AAI